Report Detail
Global Vitamin K Antagonists (VKA) Market Professional Survey Report 2019
- RnM3722177 |
- 03 September, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Vitamin K is a kind of substance with biological activity of leaf green quinone.
Rising demand from Asia-Pacific region a major driver for the growth of the market.
The global Vitamin K Antagonists (VKA) market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Vitamin K Antagonists (VKA) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Vitamin K Antagonists (VKA) market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Vitamin K Antagonists (VKA) in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Vitamin K Antagonists (VKA) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Sanofi
Bristol-Myers Squibb
Bayer
Johnson & Johnson
Genentech (Roche)
Boehringer Ingelheim
Lilly
Daiichi Sankyo
Otsuka
AstraZeneca
Pfizer
Aspen
The Medicines Company
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Oral Vitamin K Antagonists
Injection Vitamin K Antagonists
Segment by Application
VTE
ACS/MI
AF
Others
Table of Contents
Executive Summary
1 Industry Overview of Vitamin K Antagonists (VKA)
- 1.1 Definition of Vitamin K Antagonists (VKA)
- 1.2 Vitamin K Antagonists (VKA) Segment by Type
- 1.2.1 Global Vitamin K Antagonists (VKA) Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Oral Vitamin K Antagonists
- 1.2.3 Injection Vitamin K Antagonists
- 1.3 Vitamin K Antagonists (VKA) Segment by Applications
- 1.3.1 Global Vitamin K Antagonists (VKA) Consumption Comparison by Applications (2014-2025)
- 1.3.2 VTE
- 1.3.3 ACS/MI
- 1.3.4 AF
- 1.3.5 Others
- 1.4 Global Vitamin K Antagonists (VKA) Overall Market
- 1.4.1 Global Vitamin K Antagonists (VKA) Revenue (2014-2025)
- 1.4.2 Global Vitamin K Antagonists (VKA) Production (2014-2025)
- 1.4.3 North America Vitamin K Antagonists (VKA) Status and Prospect (2014-2025)
- 1.4.4 Europe Vitamin K Antagonists (VKA) Status and Prospect (2014-2025)
- 1.4.5 China Vitamin K Antagonists (VKA) Status and Prospect (2014-2025)
- 1.4.6 Japan Vitamin K Antagonists (VKA) Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Vitamin K Antagonists (VKA) Status and Prospect (2014-2025)
- 1.4.8 India Vitamin K Antagonists (VKA) Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Vitamin K Antagonists (VKA)
- 2.3 Manufacturing Process Analysis of Vitamin K Antagonists (VKA)
- 2.4 Industry Chain Structure of Vitamin K Antagonists (VKA)
3 Development and Manufacturing Plants Analysis of Vitamin K Antagonists (VKA)
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Vitamin K Antagonists (VKA) Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Vitamin K Antagonists (VKA)
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Vitamin K Antagonists (VKA) Production and Capacity Analysis
- 4.2 Vitamin K Antagonists (VKA) Revenue Analysis
- 4.3 Vitamin K Antagonists (VKA) Price Analysis
- 4.4 Market Concentration Degree
5 Vitamin K Antagonists (VKA) Regional Market Analysis
- 5.1 Vitamin K Antagonists (VKA) Production by Regions
- 5.1.1 Global Vitamin K Antagonists (VKA) Production by Regions
- 5.1.2 Global Vitamin K Antagonists (VKA) Revenue by Regions
- 5.2 Vitamin K Antagonists (VKA) Consumption by Regions
- 5.3 North America Vitamin K Antagonists (VKA) Market Analysis
- 5.3.1 North America Vitamin K Antagonists (VKA) Production
- 5.3.2 North America Vitamin K Antagonists (VKA) Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Vitamin K Antagonists (VKA) Import and Export
- 5.4 Europe Vitamin K Antagonists (VKA) Market Analysis
- 5.4.1 Europe Vitamin K Antagonists (VKA) Production
- 5.4.2 Europe Vitamin K Antagonists (VKA) Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Vitamin K Antagonists (VKA) Import and Export
- 5.5 China Vitamin K Antagonists (VKA) Market Analysis
- 5.5.1 China Vitamin K Antagonists (VKA) Production
- 5.5.2 China Vitamin K Antagonists (VKA) Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Vitamin K Antagonists (VKA) Import and Export
- 5.6 Japan Vitamin K Antagonists (VKA) Market Analysis
- 5.6.1 Japan Vitamin K Antagonists (VKA) Production
- 5.6.2 Japan Vitamin K Antagonists (VKA) Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Vitamin K Antagonists (VKA) Import and Export
- 5.7 Southeast Asia Vitamin K Antagonists (VKA) Market Analysis
- 5.7.1 Southeast Asia Vitamin K Antagonists (VKA) Production
- 5.7.2 Southeast Asia Vitamin K Antagonists (VKA) Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Vitamin K Antagonists (VKA) Import and Export
- 5.8 India Vitamin K Antagonists (VKA) Market Analysis
- 5.8.1 India Vitamin K Antagonists (VKA) Production
- 5.8.2 India Vitamin K Antagonists (VKA) Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Vitamin K Antagonists (VKA) Import and Export
6 Vitamin K Antagonists (VKA) Segment Market Analysis (by Type)
- 6.1 Global Vitamin K Antagonists (VKA) Production by Type
- 6.2 Global Vitamin K Antagonists (VKA) Revenue by Type
- 6.3 Vitamin K Antagonists (VKA) Price by Type
7 Vitamin K Antagonists (VKA) Segment Market Analysis (by Application)
- 7.1 Global Vitamin K Antagonists (VKA) Consumption by Application
- 7.2 Global Vitamin K Antagonists (VKA) Consumption Market Share by Application (2014-2019)
8 Vitamin K Antagonists (VKA) Major Manufacturers Analysis
- 8.1 Sanofi
- 8.1.1 Sanofi Vitamin K Antagonists (VKA) Production Sites and Area Served
- 8.1.2 Sanofi Product Introduction, Application and Specification
- 8.1.3 Sanofi Vitamin K Antagonists (VKA) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Bristol-Myers Squibb
- 8.2.1 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Production Sites and Area Served
- 8.2.2 Bristol-Myers Squibb Product Introduction, Application and Specification
- 8.2.3 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Bayer
- 8.3.1 Bayer Vitamin K Antagonists (VKA) Production Sites and Area Served
- 8.3.2 Bayer Product Introduction, Application and Specification
- 8.3.3 Bayer Vitamin K Antagonists (VKA) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Johnson & Johnson
- 8.4.1 Johnson & Johnson Vitamin K Antagonists (VKA) Production Sites and Area Served
- 8.4.2 Johnson & Johnson Product Introduction, Application and Specification
- 8.4.3 Johnson & Johnson Vitamin K Antagonists (VKA) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Genentech (Roche)
- 8.5.1 Genentech (Roche) Vitamin K Antagonists (VKA) Production Sites and Area Served
- 8.5.2 Genentech (Roche) Product Introduction, Application and Specification
- 8.5.3 Genentech (Roche) Vitamin K Antagonists (VKA) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Boehringer Ingelheim
- 8.6.1 Boehringer Ingelheim Vitamin K Antagonists (VKA) Production Sites and Area Served
- 8.6.2 Boehringer Ingelheim Product Introduction, Application and Specification
- 8.6.3 Boehringer Ingelheim Vitamin K Antagonists (VKA) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Lilly
- 8.7.1 Lilly Vitamin K Antagonists (VKA) Production Sites and Area Served
- 8.7.2 Lilly Product Introduction, Application and Specification
- 8.7.3 Lilly Vitamin K Antagonists (VKA) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Daiichi Sankyo
- 8.8.1 Daiichi Sankyo Vitamin K Antagonists (VKA) Production Sites and Area Served
- 8.8.2 Daiichi Sankyo Product Introduction, Application and Specification
- 8.8.3 Daiichi Sankyo Vitamin K Antagonists (VKA) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Otsuka
- 8.9.1 Otsuka Vitamin K Antagonists (VKA) Production Sites and Area Served
- 8.9.2 Otsuka Product Introduction, Application and Specification
- 8.9.3 Otsuka Vitamin K Antagonists (VKA) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 AstraZeneca
- 8.10.1 AstraZeneca Vitamin K Antagonists (VKA) Production Sites and Area Served
- 8.10.2 AstraZeneca Product Introduction, Application and Specification
- 8.10.3 AstraZeneca Vitamin K Antagonists (VKA) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Pfizer
- 8.12 Aspen
- 8.13 The Medicines Company
9 Development Trend of Analysis of Vitamin K Antagonists (VKA) Market
- 9.1 Global Vitamin K Antagonists (VKA) Market Trend Analysis
- 9.1.1 Global Vitamin K Antagonists (VKA) Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Vitamin K Antagonists (VKA) Regional Market Trend
- 9.2.1 North America Vitamin K Antagonists (VKA) Forecast 2019-2025
- 9.2.2 Europe Vitamin K Antagonists (VKA) Forecast 2019-2025
- 9.2.3 China Vitamin K Antagonists (VKA) Forecast 2019-2025
- 9.2.4 Japan Vitamin K Antagonists (VKA) Forecast 2019-2025
- 9.2.5 Southeast Asia Vitamin K Antagonists (VKA) Forecast 2019-2025
- 9.2.6 India Vitamin K Antagonists (VKA) Forecast 2019-2025
- 9.3 Vitamin K Antagonists (VKA) Market Trend (Product Type)
- 9.4 Vitamin K Antagonists (VKA) Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Vitamin K Antagonists (VKA) Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Vitamin K Antagonists (VKA). Industry analysis & Market Report on Vitamin K Antagonists (VKA) is a syndicated market report, published as Global Vitamin K Antagonists (VKA) Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Vitamin K Antagonists (VKA) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
